US Patent No: 6,150,352

Number of patents in Portfolio can not be more than 2000

Antagonists of gonadotropin releasing hormone

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

There are disclosed compounds of formula (I) ##STR1## and pharmaceutically acceptable salts thereof which are useful as antagonists of GnRH and as such may be useful for the treatment of a variety of sex-hormone related conditions in both men and women.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
MERCK & CO., INC.RAHWAY, NJ74

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Allen, Eric E Somerset, NJ 19 258
Devita, Robert J Westfield, NJ 43 327
Goulet, Mark Westfield, NJ 32 654
Jiang, Jinlong Wodbridge, NJ 30 116
Toupence, Richard B Scotch Plains, NJ 17 329
Ujjainwalla, Feroze Edison, NJ 42 172
Walsh, Thomas F Watchung, NJ 73 879
Wyvratt, Jr Matthew J Mountainside, NJ 25 323
Young, Jonathan R Dayton, NJ 43 153

Cited Art Landscape

Patent Info (Count) # Cites Year
 
MERCK SHARP & DOHME LTD. (3)
* 5,252,584 Hydroxyquinolone derivatives 18 1991
* 5,348,962 Hydroxyquinolone derivatives compounds which have pharmaceutical utility 11 1993
* 5,614,532 Quinolone derivatives 15 1994
 
SCHERING CORPORATION (2)
* 5,175,151 Antiviral compounds and antihypertensive compounds 42 1992
* 5,412,104 Ester and alkoxy substituted benzopyrans 32 1993
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
PFIZER PRODUCTS INC. (1)
6,756,385 Imidazole derivatives 3 2001
 
NOVO NORDISK A/S (12)
8,119,159 Solid oral dosage form containing an enhancer 25 2006
* 2007/0196,464 Solid oral dosage form containing an enhancer 20 2006
8,323,689 Solid oral dosage form containing an enhancer 17 2008
8,999,383 Compositions of GnRH related compounds and processes of preparation 1 2009
8,883,201 Solid oral dosage form containing an enhancer 11 2009
8,053,429 Solid oral dosage form containing an enhancer 28 2009
8,883,203 Solid oral dosage form containing an enhancer 11 2010
8,323,690 Solid oral dosage form containing an enhancer 17 2010
* 2010/0209,499 Solid Oral Dosage Form Containing an Enhancer 4 2010
9,089,484 Pharmaceutical compositions of selective factor Xa inhibitors for oral administration 0 2011
8,802,114 Pharmaceutical compositions of iron for oral administration 0 2012
8,828,431 Solid oral dosage form containing an enhancer 12 2012
 
INFINITY PHARMACEUTICALS, INC. (3)
8,785,470 Heterocyclic compounds and uses thereof 8 2012
9,181,221 Chemical compounds, compositions and methods for kinase modulation 2 2013
9,481,667 Salts and solid forms of isoquinolinones and composition comprising and methods of using the same 0 2014
 
MERRION RESEARCH III LIMITED (1)
* 2007/0148,228 Solid oral dosage form containing an enhancer 30 2006
 
PFIZER INC. (2)
* 2006/0149,066 Imidazole derivatives 0 2006
* 2008/0280,879 SUBSTITUTED HETEROCYCLIC DERIVATIVES AND THEIR PHARMACEUTICAL USE AND COMPOSITIONS 0 2008
* Cited By Examiner